Find Qualified Local Lawyers and Attorneys

CircuLite(TM), Inc. today announced that the Company has advanced its Synergy(TM) Pocket Circulatory Assist Device clinical program into a 20-patient trial designed to lead to CE Mark approval in the European Union for long-term implantation of Synergy in heart failure patients. This announcement follows successful completion of a first-in-man pilot study of Synergy in four patients. Synergy is ...